FDA sees suc­cess in mod­el-in­formed drug de­vel­op­ment pi­lot

Con­sult­ing the FDA on us­ing math­e­mat­i­cal sim­u­la­tions in drug de­vel­op­ment could make the process more ef­fi­cient, sav­ing spon­sors time and mon­ey, a re­port on the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER